Laboratory Of America Holdings ROE 2006-2018 | LH

Current and historical return on equity (ROE) values for Laboratory Of America Holdings (LH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Laboratory Of America Holdings ROE for the three months ending September 30, 2018 was 17.13%.
Laboratory Of America Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $1.46B $7.25B 20.73%
2018-06-30 $1.31B $7.04B 19.41%
2018-03-31 $1.26B $6.98B 19.53%
2017-12-31 $1.27B $6.80B 20.75%
2017-09-30 $0.72B $6.13B 12.50%
2017-06-30 $0.73B $5.88B 12.98%
2017-03-31 $0.75B $5.65B 13.66%
2016-12-31 $0.73B $5.51B 13.61%
2016-09-30 $0.66B $5.52B 12.56%
2016-06-30 $0.63B $5.31B 12.45%
2016-03-31 $0.60B $5.17B 12.10%
2015-12-31 $0.44B $4.95B 9.15%
2015-09-30 $0.45B $4.91B 10.53%
2015-06-30 $0.43B $4.77B 11.56%
2015-03-31 $0.40B $4.52B 12.56%
2014-12-31 $0.51B $2.82B 19.02%
2014-09-30 $0.52B $2.77B 19.85%
2014-06-30 $0.53B $2.66B 20.68%
2014-03-31 $0.54B $2.50B 21.09%
2013-12-31 $0.57B $2.49B 21.83%
2013-09-30 $0.57B $2.57B 21.15%
2013-06-30 $0.57B $2.66B 20.86%
2013-03-31 $0.57B $2.78B 20.95%
2012-12-31 $0.58B $2.72B 21.87%
2012-09-30 $0.60B $2.72B 22.89%
2012-06-30 $0.58B $2.63B 22.73%
2012-03-31 $0.55B $2.60B 21.67%
2011-12-31 $0.52B $2.50B 20.70%
2011-09-30 $0.52B $2.54B 20.66%
2011-06-30 $0.52B $2.58B 21.49%
2011-03-31 $0.55B $2.40B 23.67%
2010-12-31 $0.56B $2.47B 24.56%
2010-09-30 $0.57B $2.27B 26.08%
2010-06-30 $0.56B $2.21B 26.39%
2010-03-31 $0.54B $2.16B 26.16%
2009-12-31 $0.54B $2.11B 27.28%
2009-09-30 $0.52B $2.03B 27.47%
2009-06-30 $0.50B $2.01B 27.82%
2009-03-31 $0.47B $1.82B 26.81%
2008-12-31 $0.46B $1.69B 27.08%
2008-09-30 $0.46B $1.66B 26.71%
2008-06-30 $0.46B $1.80B 25.43%
2008-03-31 $0.48B $1.70B 26.36%
2007-12-31 $0.48B $1.73B 25.68%
2007-09-30 $0.47B $1.99B 24.32%
2007-06-30 $0.47B $1.93B 23.79%
2007-03-31 $0.45B $1.79B 22.88%
2006-12-31 $0.43B $1.98B 21.60%
2006-09-30 $0.42B $2.15B 21.09%
2006-06-30 $0.40B $2.01B 20.26%
2006-03-31 $0.39B $1.87B 19.50%
2005-12-31 $0.39B $1.89B 18.93%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $14.212B $10.441B
Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $63.191B 21.47
McKesson (MCK) United States $24.096B 9.20
AmerisourceBergen (ABC) United States $17.637B 12.84
Align Technology (ALGN) United States $17.540B 44.75
Cardinal Health (CAH) United States $16.008B 10.75
Henry Schein (HSIC) United States $12.976B 21.33
Cooper (COO) United States $12.517B 22.11
DENTSPLY SIRONA (XRAY) United States $8.484B 16.94
West Pharmaceutical Services (WST) United States $7.982B 39.61
Merit Medical Systems (MMSI) United States $3.220B 38.14
Patterson (PDCO) United States $2.210B 16.86
CONMED (CNMD) United States $1.902B 31.59
STAAR Surgical (STAA) United States $1.600B 164.82
Atrion (ATRI) United States $1.430B 40.87
Antares Pharma (ATRS) United States $0.503B 0.00
Lifevantage (LFVN) United States $0.210B 29.74
Invacare (IVC) United States $0.173B 0.00
Endologix (ELGX) United States $0.067B 0.00
Pro-Dex (PDEX) United States $0.058B 25.77
Aceto (ACET) United States $0.045B 0.00
Retractable Technologies (RVP) United States $0.021B 0.00
Biolase (BIOL) United States $0.021B 0.00
Milestone Scientific (MLSS) United States $0.018B 0.00